首页> 外文期刊>British Journal of Haematology >Comparison between biosimilar filgrastim vs other granulocyte-colony stimulating factor formulations (originator filgrastim, peg-filgrastim and lenograstim) after autologous stem cell transplantation: a retrospective survey from the Rome Transplant Network

【24h】

Comparison between biosimilar filgrastim vs other granulocyte-colony stimulating factor formulations (originator filgrastim, peg-filgrastim and lenograstim) after autologous stem cell transplantation: a retrospective survey from the Rome Transplant Network

机译：自体干细胞移植后生物仿制药非格司亭与其他粒细胞集落刺激因子制剂（原发性非格司亭，PEG-非格司亭和雷诺格司亭）之间的比较：来自罗马移植网的回顾性调查

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《British Journal of Haematology》 |2015年第2期|共4页
作者
Marchesi Francesco; Cerchiara Elisabetta; Dessanti Maria Laura; Gumenyuk Svitlana; Franceschini Luca; Palombi Francesca; Pisani Francesco; Romano Atelda; Spadea Antonio; Pupo Livio; Annibali Ombretta; La Malfa Antonella; Arcese William; Mengarelli Andrea;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类血液及淋巴系疾病;
关键词
growth factors; stem cell mobilization; homing; stem cell transplantation;

机译：生长因子;干细胞动员;归巢;干细胞移植;

相似文献

外文文献
中文文献
专利

1. Comparison between biosimilar filgrastim vs other granulocyte-colony stimulating factor formulations (originator filgrastim, peg-filgrastim and lenograstim) after autologous stem cell transplantation: a retrospective survey from the Rome Transplant Network [J] . Marchesi Francesco, Cerchiara Elisabetta, Dessanti Maria Laura, British Journal of Haematology . 2015,第2期

机译：自体干细胞移植后生物仿制药非格司亭与其他粒细胞集落刺激因子制剂（原发性非格司亭，PEG-非格司亭和雷诺格司亭）之间的比较：来自罗马移植网的回顾性调查
2. Comparison of biosimilar filgrastim with originator filgrastim for peripheral blood stem cell mobilization and engraftment in patients with multiple myeloma undergoing autologous stem cell transplantation [J] . Pham, Tina, Patil, Sushrut, Fleming, Shaun, Transfusion: The Journal of the American Association of Blood Banks . 2015,第11期

机译：自体干细胞移植治疗多发性骨髓瘤患者中，仿制药非格司亭与仿制药非司亭用于外周血干细胞动员和植入的比较
3. Biosimilars of filgrastim in autologous stem cell transplant: Reduction in granulocyte-colony stimulating factor costs, but similar effects on bone marrow recovery [J] . IanottoJ.-C., NgoSackF., CouturierM.-A., Leukemia and lymphoma . 2014,第1期

机译：自体干细胞移植中非格司亭的生物仿制药：减少粒细胞集落刺激因子的成本，但对骨髓恢复的影响相似
4. Factors influencing the incidence and severity of oral mucositis in patients undergoing autologous stem cell transplantation. [D] . Salvador, Prisco T. 2004

机译：自体干细胞移植患者口腔黏膜炎发生率和严重程度的影响因素。
5. Use of biosimilar filgrastim compared with lenograstim in autologous haematopoietic stem-cell transplant and in sibling allogeneic transplant [O] . Shab Uddin, Pippa Russell, Maresa Farrell, 2015

机译：与非诺格列汀相比仿制药非格司亭在自体造血干细胞移植和同种异体同种移植中的应用
6. Comparison between biosimilar filgrastim vs other granulocyte-colony stimulating factor formulations (originator filgrastim, peg-filgrastim and lenograstim) after autologous stem cell transplantation: a retrospective survey from the Rome Transplant Networ [O] . Francesco Marchesi, Elisabetta Cerchiara, Maria Laura Dessanti, 2014

机译：生物仿生蛋白酶与其他粒细胞 - 殖民地刺激因子制剂（发起料丝体刺激因子配方（发起者菲格拉特 - 菲拉特菊酯和Lenograstim）的比较：罗马移植Networ的回顾性调查

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号